GlassScriptPhysician profile
Gary Kerkvliet
NPI 1508804642
$2,973.86
in general payments reported to CMS, 2019-2025
17 companies · $1,150 in 2025
The $1,150 reported for 2025 was more than what 87% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $515 · 2020: $581 · 2021: $70.11 · 2022: $53.12 · 2024: $604 · 2025: $1,150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,754.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,754.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $487.16 | 2019-2020 | |
| Novo Nordisk INC | $485.75 | 2020-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $441.50 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Lilly USA, LLC | $369.53 | 2019-2025 | Mounjaro, Zepbound |
| Abbvie INC. | $267.44 | 2022-2025 | |
| Glaxosmithkline, LLC. | $172.65 | 2019-2025 | Shingrix |
| Pfizer INC. | $157.78 | 2020-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $149.04 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $123.81 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $79.27 | 2024-2025 | Capvaxive, Gardasil 9, Verquvo |
| Amgen INC. | $77.19 | 2024-2025 | Krystexxa |
| Exact Sciences Corporation | $51.86 | 2025 | Cologuard Collection Kit |
| Axsome Therapeutics, INC. | $46.02 | 2025 | Symbravo |
| Seqirus USA INC | $19.80 | 2025 | Flucelvax, Fluad |
| Sumitomo Pharma America, INC. | $19.41 | 2025 | Gemtesa |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $14.24 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Kerkvliet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.